The Union Budget 2026-27 exempts customs duty on medicines for seven rare diseases for personal import. The move aligns with the National Policy for Rare Diseases 2021 to reduce treatment cost burdens. The exemption aims to improve access to specialized drugs and reduce out-of-pocket expenses.
